Cancer-associated mutations in oncogene products and tumor suppressors contributing to tumor progression manifest themselves, at least in part, by deregulating microtubule-dependent cellular processes that play important roles in many cell biological pathways, including intracellular transport, cell architecture, and primary cilium and mitotic spindle organization. An essential characteristic of microtubules in the performance of these varied cell processes is their ability to continuously remodel, a phenomenon known as dynamic instability. It is therefore conceivable that part of the normal function of certain cancer-causing genes is to regulate microtubule dynamic instability. Here, we report the results of a high-resolution live-cell image-based RNA interference screen targeting a collection of 70 human tumor suppressor genes to uncover cancer genes affecting microtubule dynamic instability. Extraction and computational analysis of microtubule dynamics from EB3-GFP time-lapse image sequences identified the products of the tumor suppressor genes NF1 and NF2 as potent microtubule-stabilizing proteins. Further in-depth characterization of NF2 revealed that it binds to and stabilizes microtubules through attenuation of tubulin turnover by lowering both rates of microtubule polymerization and depolymerization as well as by reducing the frequency of microtubule catastrophes. The latter function appears to be mediated, in part, by inhibition of hydrolysis of tubulin-bound GTP on the growing microtubule plus end. Cancer Res; 74(1); 1-10. Ó2013 AACR.
Introduction
Cell division, polarization, signaling, receptor recycling, and invasion are among the morphologic processes affected during cancer progression. All these processes depend at least partially on the microtubule cytoskeleton. That regulation of microtubule dynamics and cancer progression are linked is evidenced by the fact that products of human tumor suppressor genes, for example, adenomatous polyposis coli (APC; ref. 1), AXIN (2), and von Hippel-Lindau (VHL; ref.
3) have microtubule-regulating functions. Among the tumor suppressor gene products, pVHL is well characterized with respect to its quantitative effects on microtubule dynamic instability (3) (4) (5) (6) (7) . It stabilizes microtubules by dampening tubulin turnover during both growth and shrinkage phases, and by lowering the rate of catastrophe and increasing the rate of rescue (6) . The latter two functions are by virtue of pVHL's properties as an inhibitor of GTP hydrolysis resulting in longer microtubule-end protecting GTP-tubulin caps and denser GTP remnants along the microtubule lattice (6) . The APC and AXIN gene products also work as mediators of microtubule cytoskeleton formation, APC as a promoter of microtubule assembly (8) , and AXIN as a promoter of de novo microtubule nucleation at the centrosome (2) .
Given the broad role that microtubules play in cancerrelated cellular processes, we sought to systematically identify genes encoding tumor suppressors, whose functional inactivation is invariably associated with the development of various aspects of the malignant phenotype, on the basis of their ability to affect microtubule dynamic instability. We undertook a focused siRNA screen targeting 70 tumor suppressors and assessed the functional impact of downregulation of these genes on microtubule dynamic instability using a previously established live-cell imaging assay that relies on the tracking of a microtubule plus tip (þTIP) binding protein as a proxy for both microtubule growth and shrinkage dynamics (9) . Among the hits of this siRNA screen, the neurofibromatosis 1 and 2 (NF1 and NF2) genes emerged with high confidence as robust stabilizers of microtubule dynamics. The choice of NF2 for further analysis was rooted in the fact that NF2 has been found 
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≥2, Poor Figure 1 . Screening of tumor suppressors with microtubule-regulatory functions. A, extraction of microtubule (MT) dynamics by automated tracking of EB3 comets; (i) raw image of EB3-GFP tagged comets associated with growing microtubule ends (contrast inverted; bar, 10 mm); (ii) microtubule growth tracks color coded by speed (mm * min À1 ); (iii) initiation points of forward gaps in growth trajectories (yellow, inferred pause events) and backward gaps (red, inferred, rescued shrinkage events). B, elimination of low-quality movies based on stability in the comet number; (i) acceptable (inlier) movies contain a constant number of detectable comets over the entire duration; (ii) rejected (outlier) movies display a significant drift in the comet number. C, summary of interoligo heterogeneity quantified by the number of parameters (out of 4), where P < 0.01 between any oligo pair (3 oligos per target). D, variation of median microtubule growth speed across all 1,143 movies of the primary screen. Vertical lines, days of filming. Orange and red blocks, cells thawed from one master stock. Blue dots, Allstar control movies; black dots, Negctrl control movies; green, red, cyan, magenta, yellow circles, movies per color belonging to 1 of 70 siRNA-targeted genes; black crosses overlaid to dots/circles, eliminated movies due to low image quality (see B); red crosses overlaid to dots/circles, eliminated movies due to group inconsistency (see Materials and Methods). (Continued on the following page.) mutated in human clear-cell renal cell carcinoma (ccRCC) in a manner that appears to be mutually exclusive with VHL (10) and that pVHL is known to quantitatively affect multiple parameters of microtubule dynamic instability (6), making one wonder about possible parallels in their role as tumor suppressors in certain tumor cell biologic contexts. NF2 encodes NF2/Merlin, a ubiquitously expressed member of the ERM (Ezrin-Radixin-Moesin) protein family. Mutations in the NF2 gene cause neurofibromatosis type-2, a cancer syndrome characterized by the development of tumors of the nervous system (11) . NF2 tumor suppressor is also dysfunctional in diverse nonnervous malignancies such as mesotheliomas (12) , colorectal cancer (13), melanomas (14) , and ccRCC (10) . NF2 exerts its tumor suppression activity through multiple distinct pathways including activation of the Hippo pathway (15) , induction of a growth suppressive program through inhibition of CRL4 E3 ubiquitin ligase (16) , establishment of epithelial adhesion and polarity via Par3 and aPKC (17) , insurance of proper centrosome positioning and spindle orientation (18) , and maintenance of Rac-dependent anterograde microtubule-based trafficking of exocytic vesicles (19) . Finally, the Drosophila homolog of NF2 has been detected in cytoplasmic particles that move along microtubules (20) and in vitro association of recombinant NF2 with polymerized microtubules has been observed (21) .
Our screen and detailed analysis of NF2 function now establishes the NF2 gene product as a potent stabilizer of microtubules both by attenuation of tubulin turnover through reduction of the rates of microtubule polymerization and depolymerization and by reducing the frequency of microtubule catastrophes.
Materials and Methods

Biochemical and cell biological methods
Biochemical and cell biologic materials and methods are described in the Supplementary Information.
Live cell imaging
Movies were acquired with an Olympus IX70 Delta Vision Spectris microscope (Applied Precision) at 37 C using a Â60 1.4NA DIC Oil PlanApo objective: exposure time 200 ms, frame rate 1.25 Hz. For the screen, four movies were acquired per well, 150 frames per movie. A total of 1,143 movies were acquired for the 70 genes plus controls over a span of 25 days. For the validation screen, an additional 220 movies were acquired for 12 selected genes plus controls over a span of 4 days ( Supplementary Fig. S1B ). For NF2 validation, the acquisition protocols were the same except that we acquired >8 movies per well. For nocodazole experiments, a first movie was acquired in 300 mL of normal growth medium and then 300 mL of growth medium containing 80 nmol/L nocodazole was added (final concentration 40 nmol/L). Video sequences were acquired before (0) and 20, 120, and 360 seconds after nocodazole addition as described.
Analysis of microtubule dynamics from EB3-GFP comet data and tracking data validation An analysis of Microtubule Dynamics from EB3-GFP comet data tracking and data validation methods is described in the Supplementary Information.
Results
NF1 and NF2 emerge as high confidence hits among 70 tumor suppressor genes screened for effects on microtubule dynamics
To identify tumor suppressors with previously unappreciated roles in microtubule regulation, we designed a live-cell imaging screen for effects on the dynamic behavior of microtubules upon siRNA-mediated depletion. We employed RPE-1 cells stably expressing a GFP-fusion to the þTIP tracking protein EB3 (Fig. 1A, i) . The screen was conducted in 8-well chambers. Per target gene, three siRNA oligos were transfected independently in three wells. In every chamber, we further transfected RPE-1 cells in separate wells with two siRNA control oligos: Allstar and Negctrl (Supplementary Data file, "siRNA information"). Thus, per chamber, two genes were targeted with corresponding negative controls. A total of 1,143 EB3-GFP movies were acquired over 25 days.
Image time-lapse sequences were then analyzed using the plusTipTracker software (22) . The package offers modules for detection and tracking of EB3-GFP comets (Fig. 1A , ii) and for inference of pauses and shrinkage events, in which the comets temporarily disappear (Fig. 1A, iii) . Thus, we obtained in a fully automated and unbiased fashion statistics of microtubule dynamic behaviors that included their growth, pausing, and shrinkage characteristics. The software generates >80 metrics to quantify the full spectrum of microtubule dynamics. Fifty of those are documented for each movie (Supplementary Data file, "Metrics" and "Movie Documentation").
Before analyzing putative effects of siRNA oligos on these parameters, we performed a thorough assessment of the data quality (see Materials and Methods). First, we excluded movies (12 in total) in which a high variation of detected comets over time suggested inconsistent image acquisition, (Continued.) E, evaluation of effects on 4 analyzed parameters: growth speed (red), growth phase lifetime (magenta), pause frequency (blue), shrinkage speed (black); for a detailed description of all parameters and effects see Supplementary Data file. Shown are the Àlog P values of a permutation t test evaluating the difference between microtubule dynamics in movies of cells transfected with targeting siRNA and microtubule dynamics in movies of cells transfected with nontargeting Allstar (y-axis north) or nontargeting Negctrl (y-axis south) siRNAs. Dashed lines, the Àlog P values testing the difference in the same parameters between movies of cells transfected with Allstar and movies of cells transfected with Negctrl siRNA. Asterisks, targets with parameters where the difference between target effect and control data is more significant than the difference between the two controls. Gray bars, 12 targets selected for a validation screen.
for example, due to focus drift or photobleaching ( Fig. 1B and Supplementary Movie S1). Second, we tested the consistency of effects between the three oligos targeting the same gene by pairwise comparison of oligos in four metrics (Supplementary Data file, "Oligo Variation"). Quite remarkably, 49 of the 70 genes showed no difference in any of the 12 pairwise tests (Fig. 1C) . This high level of consistency suggests two possibilities: either all three oligos affect microtubule dynamics in an identical fashion, or they do not cause any detectable change in microtubule dynamics. Another 20% of the genes (14/70) showed a difference in only one of the 12 tests, whereas the final 10% (7/70) showed a difference in two or more. None of the genes had a single, unambiguously deviant oligo across the four metrics, which would have indicated transfection or targeting failure. Thus, we felt confident in pooling the movies for one target into a single group of typically 12 movies. Third, we tested the intra-group consistency among these movies and eliminated an additional 42 movies as outliers.
Variation analysis of individual metrics across all movies displayed significant heterogeneity in the data. This is a notorious problem of live-cell screens where even small changes in cell culture conditions penetrate into the readouts (23) . In our case, it was obvious that the cell population systematically drifted in particular metrics, most likely coupled to the increasing number of passages (Fig. 1D ). To identify tumor suppressor genes with significant contributions to the regulation of microtubule dynamics, it was therefore necessary to compare the validated set of movies for a target gene to the control siRNA movies filmed on the same day. We performed two-tailed permutation t tests between these movie groups for each of the 50 metrics (Supplementary Data file, "Target Analysis"). Figure 1E shows the P values of these tests for the four metrics: growth speed, growth lifetime, pause frequency, and shrinkage speed (solid lines). An analogous test was performed between the Allstar and Negctrl movies for each day (Fig. 1E , dashed lines; Supplementary Data file, "Control Data Analysis"). This latter analysis revealed that two nominally nontargeting oligos can produce differences with high statistical significance in many metrics, some of which were comparable to the differences between the effects of a particular target knockdown and Allstar. To avoid a high rate of false positives, we therefore reasoned that valid hits should produce an effect upon knockdown that is more significant than the difference between the two controls (Allstar and Negctrl) on the same day. For instance in Fig. 1E NF1 fulfills this criterion for the growth speed, which is also documented in Supplementary Fig. S1A , where the siRNA condition shows an increase in growth velocity that is greater than the difference in growth velocity measured between Allstar and Negctrl on the same day. The same applies to the shrinkage speed for NF1 and NF2 (the latter is illustrated in Supplementary Fig. S1A ). In contrast, the CASP8 and FADD-like apoptosis regulator (CFLAR) presents an example where the difference between target knockdown and Allstar is highly significant (P < 10 À12 ). However, no significant difference is observed between the knockdown and Negctrl.
In view of these differences between control conditions, we identified hits by testing for each target which of the 50 metrics had P values <0.05 both in the target/Allstar and in the target/Negctrl comparisons and smaller than the P value in the associated Allstar/Negctrl test (Supplementary Data file, "Target Analysis"). The target genes were then ranked by how many metrics were significant according to this criterion (Supplementary Data file, "Target Ranking"). Because some metrics are redundant, we reduced the set for the final ranking to 23 nearly orthogonal parameters. The highest ranked genes with more than 50% of the metrics fulfilling the criterion for an affected behavior were NF1, TGFBR2, SCRIB, BARD1, SHH, and SMARCB1. Other high-ranking genes with more than 30% of the metrics changed included LATS1, LATS2, NF2, P63, and BRCA1. Surprisingly, two other genes known to affect microtubule dynamics, VHL and AXIN, did not rank particularly high in our screen. To understand this result, we examined the control movies on the corresponding days (days 1 and 10, respectively) and noticed a particularly wide discrepancy between the Allstar and Negctrl populations in mean growth speed ( Supplementary Fig. S1B ) and in several other metrics (Supplementary Data file, "Control Data Analysis"). Therefore, for validation, we decided to repeat the screen for 12 targets of high interest (highlighted in Fig. 1E , without CFLAR). Ten genes were chosen on the basis of their oligo consistency (or lack thereof) and target ranking, plus VHL and AXIN. The Supplementary Data file, "Comparison First-Second" summarizes the results for each of the 12 selected target genes in the primary and secondary validation screen. Consistency between the two screens was performed again under the requirement that siRNA effects in both screens significantly changed a metric relative to Negctrl and Allstar, and that the changes were greater than the differences between the two control conditions. To minimize the risk of false positives, we increased the stringency of these tests to a 99% confidence level, i.e., all two-sided permutation t tests had to return a P value <0.01 to pass.
NF1 and NF2 were the only two genes to show such high consistency between primary and secondary validation screen. Of these two tumor suppressor genes, NF2 shares notable features with VHL with regards to tumor suppression in the context of kidney cancer. Whole-exome sequencing revealed that both genes are mutated in human ccRCC (10) . It is conceivable that loss of function in either VHL or NF2 contributes to ccRCC development through the dysregulation of similar cellular processes, including microtubule regulation. Hence, we focused next on further analysis of the effect of NF2 on microtubule dynamics.
Validation of NF2 as a microtubule stabilizing protein
We engineered two additional sets of cell lines in which NF2 protein levels were manipulated and EB3-GFP comets tracked. First, we depleted NF2 in EB3-GFP-expressing RPE-1 cells by stably expressing shRNAs targeting NF2. Two distinct shRNAs, shNF2.1 and shNF2.2, reduced NF2 protein levels to similar degree; a nonsilencing scrambled shRNA control (ns) did not demonstrate such effects ( Fig. 2A) . Second, NF2-negative mesothelioma cancer cells already stably expressing EB3-GFP (referred to as Meso33-EB3-GFP) were engineered to stably express wild-type NF2 or vector control. NF2 production in these cells was confirmed by immunoblotting (Fig. 2B) .
Using the plusTipTracker package, we then analyzed microtubule dynamics in live-cell images (Supplementary Data file, "NF2 Validation Experiments"). As shown in Fig.  2C and D, EB3-GFP tracking in these cells supports the finding from the screen that NF2 is a strong microtubule stabilizer. Both NF2 depletion in RPE-1 cells and reconstitution of NF2 gene expression in Meso33-EB3-GFP cells show highly consistent, complementary effects on microtubule dynamics. First, NF2 decreases both microtubule polymerization and depolymerization rates as evidenced by the changes in "growth and shrinkage speeds," respectively, indicating that it influences the net turnover of tubulin dimers at the microtubule plus end in both phases. Second, NF2 increases the time of EB3-GFP presence at the microtubule plus end as expressed by "growth lifetime" metric, suggesting that NF2 protects the growing plus end of microtubules and therefore reduces catastrophe rates as defined by 1/t growth . The net distance of microtubule growth (growth length) shows no significant changes, indicating that the prolonged growth phases are compensated by lower growth rates. Third, NF2 influences microtubule shrinkage not only by reducing shrinkage speeds, but also net distance of shrinkage (shrinkage length). Since the "shrinkage lifetime" (t shrink ) does not show consistent results and does not change significantly, the shorter net distance of shrinkage in presence of NF2 is primarily associated with the lower disassembly rate. Fourth, although NF2 dampens growth and shrinkage speeds and prolongs growth times and therefore has a net stabilizing effect on dynamic microtubules, it significantly reduces "pause lifetime" in which pause is measured as the time between loss of an EB3-GFP signal and regain of growth, resulting in a forward gap closure (22) . This observation suggests that NF2 might influence reinitiation of 2) and expression of a nonsilencing shRNA as control (ns); anti-NF2 (top) and antitubulin (bottom). B, Western blot analysis showing stable reexpression (LKO-1-CMV) of NF2 using lentiviral expression in NF2-deprived mesothelial cancer cells (Meso33), expression of the empty vector serves as control (ctrl); anti-NF2 (top), antitubulin (bottom). C, microtubule dynamic parameters in RPE-1 cells measured by EB3-GFP comet tracking. Box and whisker plots representing tracks for growth speed, growth lifetime, growth length, pause lifetime, shrinkage speed, shrinkage lifetime and shrinkage length are shown from three independent experiments: per condition over 60,000 tracks (N) were measured from a minimum of 8 movies. Boxes indicate 25, 50 (median), and 75% quantiles; whiskers extend to 1.5Â the interquartile range; red dots, outliers beyond this range. Notched boxes, uncertainty of the median. Boxes whose notches do not overlap indicate that the medians of the two clusters differ at the 5% significance level ( ÃÃÃ , P < 0.0001; ÃÃ , P < 0.001; Ã , P < 0.05; Student t test). D, microtubule dynamic parameters in Meso33 cells as described in C. microtubule plus end polymerization by faster recruitment of þTIPs including EB3-GFP.
NF2 colocalizes and interacts with tubulin and acetylated tubulin
Given the prominent effects of NF2 on microtubule dynamics, we next sought for cell biologic and biochemical evidence for interactions of NF2 with microtubules in vivo. As shown by indirect immunofluorescence microscopy, endogenous NF2 associates with the microtubule network in RPE-1 cells (Fig. 3A) . Immunofluorescence stainings for NF2 either in the presence of bacterially purified glutathione-S-transferase (GST)-NF2 fusion proteins or in cells that had been previously depleted for NF2 by shNF2 expression revealed that the staining and thus the detected colocalization of NF2 with microtubules is specific ( Supplementary Fig. S2A-S2D ).
To corroborate this finding, we immunoprecipitated tubulin from RPE-1 cells ectopically producing NF2 and observed specific coimmunoprecipitation of NF2 (Fig. 3B) . Also, endogenous NF2 coimmunoprecipitated specifically with tubulin antibody (Fig. 3C) . These results provide biochemical evidence that NF2 and tubulin interact in vivo.
The notion, that NF2 mainly colocalizes to microtubule bundles (Fig. 3A, zoom) and not to all microtubules present in the cell let us wonder whether NF2 interacts with modified forms of tubulin. Indeed, immunofluorescence stainings show that NF2 colocalizes with the acetylated form of tubulin (Fig.   3D ). Consistent with this, we also found that ectopically produced NF2 coimmunoprecipitated with an acetyl-tubulin-specific antibody in RPE-1 cells (Fig. 3E) . Since tubulin modifications are indicative for a differential turnover and stability (reviewed in ref. 24) , we additionally investigated the state of tubulin tyrosination in cells depleted for NF2. Neither in Meso-33 cells reconstituted with wild-type NF2, nor in RPE-1 cells depleted for NF2, we detected differences in tubulin tyrosination state as assessed by Western blotting or immunofluorescence microscopy ( Supplementary Fig. S3 ).
NF2 is a microtubule protector and stabilizer by increasing GTP-tubulin frequency along the lattice and on the plus end
To further characterize NF2's microtubule regulatory function, we asked whether NF2 has the capability of protecting microtubules from the depolymerizing activity of nocodazole (25) . We first determined in an initial experiment with low (1 mmol/L) and high (10 mmol/L) concentrations of nocodazole, the amount of nocodazole needed in RPE-1 cells depleted for NF2 to obtain a measurable effect (Supplementary Fig.  S4A ). While NF2-depleted cells displayed statistically significant tendency of higher sensitivity towards nocodazole treatment already at 1 mmol/L, robust effects were only found at 10 mmol/L concentration. As illustrated in Fig. 4A , at this concentration the number of cells displaying stable microtubules was significantly reduced for NF2-depleted RPE-1 cells
Anti-acetyl-tubulin
Anti-NF2 Merge compared with control cells. Conversely, reexpression of NF2 in Meso-33 cells significantly increased the number of positive cells with stable microtubules after nocodazole treatment (Fig. 4B) . Quantification of these data revealed a strong protection function of NF2 towards nocodazole-induced microtubule depolymerization (Fig. 4C and D) . A and B, representative pictures from RPE-1 cells expressing control (ns) or shRNA against NF2 (shNF2.1) and Meso33 cells expressing a control (ctrl) or NF2 (NF2) processed for immunofluorescence using an antitubulin antibody (green) before (top) or after (bottom) treatment with 10 mmol/L nocodazole for 20 minutes. DAPI was used to stain the DNA (blue). Bar, 10 mm. C and D, quantification of cells treated as described in A and B. Cells were scored for the presence of stable microtubules before (blue bars) and after (green bars) treatment with nocodazole. The bars represent mean values from three slides per condition from two independent experiments (N > 1,000 cells scored per condition; ÃÃÃ , P < 0.0001, Student t test). E, livecell imaging and EB3-GFP particle tracking before (0 seconds) and after the addition of 40 nmol/L nocodazole to Meso33 ctrl and Meso33 NF2 cells (see Fig. 2B, iii) . Loss of EB3-GFP signals and slowdown of growth and shrinkage speeds at 20, 120, and 360 seconds post-nocodazole addition is shown as a ratio to the same parameters measured before drug addition. For every time point the mean AE SD of three movies from three different plates are shown (> 8,000 tracks per condition). F, polymerization curves of MAP-purified tubulin in the presence of NF2 or GST alone. For every time point the mean AESD of three independent experiments is shown; Ã , P < 0.05. G, bar graphs depicting the area under curves from F, background subtracted mean AE SD; Ã , P < 0.05; ÃÃ , P < 0.01. H, immunofluorescence costaining with anti-a-tubulin (green) and anti-GTP-tubulin (red) antibodies in Meso33 cells reconstituted with NF2 or the empty vector as control (ctrl). White arrowheads, GTP-tubulin remnants on the microtubule lattice; yellow arrows, GTP-capped microtubule plus ends. Bar, 10 mm. I, GTP-tubulin remnant signal intensity relative to tubulin intensity in RPE-1 cells with a stable NF2 knock down (left) or Meso33 cells reconstituted with NF2 (right). The bar graphs represent mean AE SD ( Ã , P < 0.05; Student t test) from three independent experiments of each 15 cells. J, quantification of the distance between GTP-tubulin remnants on microtubules in cells described in I. The bar graphs represent mean AE SD ( ÃÃÃ , P < 0.0001; Student t test) from three independent experiments (each experiment minimum 12 cells and N > 500 distance measurements). K, percentage of the GTP-tubulin presence at the microtubule tips in cells described in I. The bar graphs represent mean AE SD ( ÃÃ , P < 0.001; Student t test) from three independent experiments (each experiment minimum 5 cells and N > 100 tips).
To obtain more detailed insights into the mechanism underlying NF2-mediated protection of microtubules from nocodazole-induced depolymerization, we treated Meso33 (ctrl) and Meso33(NF2) cells with substoichiometric concentrations of nocodazole (40 nmol/L) and measured the transient effects of this agent on EB3-GFP particle dynamics over a time course of 6 minutes after perfusion. As previously shown, this treatment causes increased EB3-GFP disappearance over time (6) . Meso33(NF2) cells displayed a significantly lower decay in particle number as Meso33(ctrl) cells (Fig. 4E, panel 1) . Relative growth and shrinkage speeds were also differentially affected by NF2 status (Fig. 4E, panels 2  and 3) . Notably, NF2's effect on relative growth and shrinkage rate reduction is most critical during the first 20 seconds of nocodazole-induced depolymerization. It is conceivable that once nocodazole reaches an equilibrium in the system (that is when it binds to its cognate binding site on microtubules; ref. 5), decreases in relative growth and shrinkage speeds are very similar. A possible explanation for this phenomenon might be that NF2 reduces nocodazole binding to microtubules in a noncompetitive manner. However, as discussed before, the relative comet numbers show a constant decrease over time in Meso33(ctrl) compared with Meso33(NF2) cells. This implies that at least over the time period of our analysis, NF2 continually stabilizes the microtubule plus end during nocodazole treatment.
An earlier report demonstrated that NF2 enhances polymerization of tubulin in vitro, although to a smaller extent when compared with adding microtubule-associated proteins (MAP) to the pure tubulin fraction (21) . To further validate this finding and get additional insight into whether NF2 enhances also microtubule polymerization in vitro in the presence of MAPs, we performed tubulin polymerization assays of MAP-purified tubulin fractions (containing 30% MAPs) in the presence of purified NF2 (Supplementary Fig.  S4B ). Our results show that even in the presence of MAPs, NF2 leads to enhanced tubulin polymerization when compared with controls ( Fig. 4F and G) .
It is well established that microtubule turnover is strongly affected by the presence of the GTP-form of tubulin. The latter stabilizes microtubules at the plus end by decreasing catastrophe rates and, along the entire microtubule lattice, by increasing rescue rates (26) . We have previously observed a strong effect of pVHL on GTP-remnant frequency and GTPcapping (6) . Therefore, we investigated whether NF2 would also influence the localization, intensity, and frequency of GTP tubulin on the microtubule lattice by indirect immunofluorescence microscopy. In both cell systems, we costained tubulin and GTP-tubulin with respective antibodies (Fig. 4H) and quantified signal intensities, frequencies, and distances between GTP-remnants. Interestingly, analysis of the net intensities of the GTP-tubulin signal showed that NF2 presence leads to enhanced signals in both cell systems (Fig. 4I) . Moreover, distance measurements between GTP-remnants along the microtubule lattice as well as quantification of microtubule plus end GTP-capping frequencies demonstrated that both parameters are significantly affected depending on NF2 status ( Fig. 4J and K) . This observation is in line with the previous findings, that NF2 presence prolongs the growth lifetime (correlates with more GTP capping) and reduces the shrinkage length distance (correlates with GTP remnants distances). Collectively, these data strongly imply that NF2 is influencing the intrinsic GTP hydrolysis rate of tubulin to GDP and P i , which is translated in changed dynamic parameters.
Finally, given the striking parallels between pVHL and NF2 in microtubule dynamics control, we were wondering whether these two tumor suppressor proteins display any cooperativity with respect to effects on microtubule dynamics. We employed a nocodazole protection assay in VHL-negative ccRCC cell line RCC4 (RCC4 ctrl) and the corresponding counterpart engineered to reexpress wild-type pVHL (RCC4 VHL30). As these cells are wild-type for NF2 expression we depleted in both of these cell lines NF2 with shNF2.1 or used a nonsilencing shRNA (ns) for control ( Supplementary  Fig. S4C ). While single depletion of the tumor suppressor proteins under investigation showed reduced protection from nocodazole-mediated microtubule depolymerization their combined absence did not enhance this effect (Supplementary Fig. S4D ), implying a lack of cooperation between NF2 and pVHL loss-of-function in the context of their microtubule regulatory function.
Discussion
Our live-cell imaging analysis of the effects of RNAi-mediated knockdown of a collection of 70 tumor suppressor gene products identified NF2 as a key regulator of microtubule dynamics, besides 10 other genes, including LATS2 and BRCA1, which have known cytoskeleton interactions, at least during mitosis at the centrosome (27, 28) . These hits passed stringent selection criteria requiring robust shifts of a high-dimensional parameter set relative to variations between internal control siRNAs. AXIN and VHL, two other tumor suppressor gene products with known effects on microtubule dynamics (2, 6), however, were not identified as potential hits. In these cases the drop-out criteria were strongly influenced by heterogeneous effects of control siRNA in the primary screen. Given the established roles these two tumor suppressor proteins play in microtubule regulation, it is possible that our screen contains additional false negatives. It also sheds light on the challenges of interpreting the outcome of live-cell screens based on sensitive, multivariate readouts of subcellular behaviors (23, 29) . Actual targeting effects in the multidimensional readout metric are confounded by variations in penetrance of the perturbation and in the basal states of the cell population that can easily reach statistically significant differences between repeats. Thus, statistical tests alone are insufficient to identify true hits, but a series of fairly subjective choices must be made for the extraction of cell biologically meaningful targets.
NF2 is mutated in a mutually exclusive manner with VHL in ccRCC and like pVHL affects multiple parameters of microtubule dynamic instability, which in combination result in net stabilization of microtubule dynamics. First, NF2 reduces net tubulin turnover at the growing as well as at the shrinking microtubule plus end resulting in slower growth and shrinkage speeds. Second, due to prolonged phases of growth, NF2 reduces catastrophe rates, which may be the result of higher microtubule GTP-cap frequencies observed in NF2-positive cells. Third, besides stabilizing effects in microtubule growth phases, NF2 also reduces the shrinkage distance after a catastrophe event, which is in line with a higher GTP remnant frequency along the microtubule lattice in NF2-expressing cells. GTP remnants coincide with microtubule rescue sites, promoting a switch from shrinkage to growth (6, 26) . Biochemically, these effects might be directly linked to NF2 interaction with microtubules as evidenced by coimmunoprecipitation with tubulin and acetyl-tubulin. This interaction may be either direct, mediated through two previously identified tubulin-binding sites in NF2 (21) , or indirect, interceded by kinesin or dynein motor proteins (20) . Irrespective, loss of NF2 microtubule stabilizing effects might translate, for example, into altered vesicle trafficking (19) , failure of contact inhibition in concert with the actin cytoskeleton remodeling (30) (31) (32) , or changes in centrosome positioning (18) .
While NF2 and pVHL demonstrate striking similarities with respect to their effects on microtubule dynamic instability, we failed to observe cooperativity between NF2 and pVHL loss-of-function in the protection from nocodazole-mediated microtubule depolymerization. This supports the view that these tumor suppressors may mediate their stabilizing effects through similar and probably overlapping, mechanisms. pVHL's microtubule regulatory function has been linked to the maintenance of the microtubule-based axoneme in the primary cilium and suppression of renal cysts (33) , precursor lesions of ccRCC. Deletion of Nf2 in the proximal convoluted epithelium of the kidney in mice produces also neoplasia that progressed to invasive carcinoma (34) . Given this and the fact that both pVHL and NF2 display microtubule regulatory functions, it is conceivable that loss of NF2 in ccRCC may predispose to renal pathology. Thus, disruption of microtubule dynamics may be a common mechanism of renal cysts formation induced by loss of different tumor suppressor proteins that share common tumor suppressor mechanisms.
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